Ray Dalio Dexcom Inc Transaction History

Bridgewater Associates, LP

$17.3 Billion
Q3 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Dexcom Inc stock. As of the latest transaction made, Bridgewater Associates, LP holds 319,629 shares of DXCM stock, worth $25.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

319,629

Previous 347,324 7.97%

Holding current value

$25.3 Million

Previous $39.4 Million 45.6%

% of portfolio

0.12%

Previous 0.21%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $1.77 Million - $3.21 Million	-27,695 Reduced 7.97%	319,629 $21.4 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $2.6 Million - $3.31 Million	-23,540 Reduced 6.35%	347,324 $39.4 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $7.11 Million - $8.73 Million	-62,291 Reduced 14.38%	370,864 $51.4 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $12.7 Million - $20.9 Million	-168,208 Reduced 27.97%	433,155 $53.8 Million
Q3 2023 Nov 13, 2023	BUY	$86.06 - $137.93 $15.8 Million - $25.3 Million	183,141 Added 43.79%	601,363 $56.1 Million
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $4.18 Million - $4.87 Million	-37,149 Reduced 8.16%	418,222 $53.7 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $2.48 Million - $2.93 Million	23,847 Added 5.53%	455,371 $52.9 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $16.3 Million - $23.5 Million	-191,759 Reduced 30.77%	431,524 $48.9 Million
Q3 2022 Nov 10, 2022	SELL	$76.35 - $94.18 $746,015 - $920,232	-9,771 Reduced 1.54%	623,283 $50.2 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $33.2 Million - $64.8 Million	487,813 Added 335.86%	633,054 $47.2 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $3.64 Million - $5.04 Million	38,707 Added 36.33%	145,241 $74.3 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $1.59 Million - $2 Million	12,281 Added 13.03%	106,534 $57.2 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $1.19 Million - $1.6 Million	-11,159 Reduced 10.59%	94,253 $51.5 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $5.58 Million - $7.43 Million	68,880 Added 188.55%	105,412 $45 Million
Q1 2021 May 14, 2021	BUY	$84.79 - $104.74 $339,838 - $419,797	4,008 Added 12.32%	36,532 $13.1 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $1.18 Million - $1.58 Million	15,105 Added 86.72%	32,524 $12 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $1.66 Million - $1.97 Million	17,419 New	17,419 $7.18 Million

Others Institutions Holding DXCM

# of Institutions

1,015

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.6B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account